Tasly Pharma Trials Qishen Yiqi Pills for Chronic Heart Failure
Tasly Pharmaceutical is conducting a trial to assess the efficacy and safety of Qishen Yiqi Dripping Pills for chronic heart failure with reduced ejection fraction.
Asset / Drug
Drug and asset intelligence for Tasly with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.